Skip to content

A clinical trial to study the effects of two drugs Ashwagandhadi Vati and Trayodashanga Guggulu in the Management of knee sandhivata with special reference to Degenerative Knee Arthritis

A Comparative Study on Ashwagandhadi Vati & Trayodashanga Guggulu in the Management of Janusandhigatvata with special reference to Knee Osteoarthritis

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/09/021291
Enrollment
84
Registered
2019-09-17
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M179- Osteoarthritis of knee, unspecified

Interventions

Intervention1: Ashwagandhadi Vati: The 42 patients of group one will be treated with oral administration of Ashwagandhadi vati 1 gm twice a day for 12 weeks and the another group of patients with Tray

Sponsors

Dr Anagha Kothadia
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Male or Female of 30 to 70 years age group Patients having signs & symptoms of Janusandhigatvata

Exclusion criteria

Exclusion criteria: Patient with known history of rheumatoid arthritis, cancer, gout, uncontrolled hypertension, uncontrolled diabetes, unstable renal hepatic, cardiac disorder, paralysis. Severe arthritis, bed ridden and unable to walk without assistance Pregnant, lactating women Patients with known contraindication to any ingredient of trial drug Patients having infections of spine especially tuberculosis

Design outcomes

Primary

MeasureTime frame
Change in knee pain and knee functionTimepoint: 12 weeks

Secondary

MeasureTime frame
Change in symptoms other than knee pain and knee functions Comparison between two drugs Knee quality of life and overall healthTimepoint: 12 weeks

Countries

India

Contacts

Public ContactDr Anagha Kothadia

R A Podar Ayurved College

geeta.parulkar@gmail.com08652694332

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026